Purchase Order HHSD2002015M62682P
- Not listed
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract, valued at $145,412.23, is for the provision of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies, including the National Institutes of Health,...
- This is a $101,594.39 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has an existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, and has received prior federal contract...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $95,931.00 contract is for the provision of laboratory equipment, with no set-aside designation used. Based on Illumina's prior federal contract work, the equipment is likely to include NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along...
- This is a $95,931.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc. for the provision of laboratory equipment. The award does not indicate the use of any set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has a history of providing sequencing systems and related products to support genomic research and diagnostics across various federal...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
- This is a purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents. The $137,112.53 firm fixed price contract is for the delivery of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems and related consumables and services to support genomic research and diagnostics for various federal agencies, including the National...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This is a $96,525.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and consumables. The contract is for the provision of a SEQUENCER device and does not have a set-aside designation. Illumina has previously held prime contracts and subcontracts across federal agencies, including the National Institutes of Health, U.S. Department of Agriculture, and Department of Veterans Affairs,...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs. This award does not appear to be associated with a larger contract vehicle, but Illumina holds an Indefinite Delivery Contract worth up to $3.3 million with the Department of the Navy to supply sequencing platforms and consumables for biological threat characterization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.9k | 5/22/15 |